Related Experiment Video
Updated: Aug 13, 2025

07:37
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
2.9K
BTG1 mutation yields supercompetitive B cells primed for malignant transformation
Coraline Mlynarczyk1, Matt Teater1, Juhee Pae2
1Division of Hematology and Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Summary
Mutations in BTG1 allow B cells to become supercompetitors, leading to aggressive lymphomas. This disrupts immune cooperation, highlighting an evolutionary trade-off in cell competition.
Area of Science:
- Immunology
- Cellular Biology
- Evolutionary Biology
Background:
- Multicellular organisms rely on cellular cooperation.
- The adaptive immune system, particularly germinal center B cells, exhibits intense competition for survival signals.
- Understanding the regulation of B cell competition is crucial for immune function and disease.
Purpose of the Study:
- To investigate the role of BTG1 in regulating B cell fitness during antibody affinity maturation.
- To identify the molecular mechanisms by which BTG1 mutations impact B cell competition.
- To understand the link between disrupted B cell competition and lymphoma development.
Main Methods:
- Analysis of primary human lymphomas.
- Development of novel mouse models.
- Investigation of MYC protein induction kinetics.
Main Results:
- Mutations in BTG1 disrupt a key immune gatekeeper mechanism.
- Disruption leads to B cells becoming 'supercompetitors' that outcompete normal cells.
- Altered MYC protein induction kinetics underlie this enhanced competitiveness.
- This process results in aggressive, invasive lymphomas associated with poor clinical outcomes.
Conclusions:
- BTG1 is a critical regulator of B cell competition during immune responses.
- Disruption of this gatekeeper mechanism can drive lymphoma formation.
- There is an evolutionary trade-off between immune-driven cell selection and unicellular-like competition.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K

